Clinical Trials for Klus Pharma

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Klus Pharma

Clinical Trials (3)

NCT05816252
A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)
PHASE2Active, not recruiting
356 participants
Started: Apr 19, 2023 · Completed: Oct 30, 2026
1 condition2 sponsors60 locations
NCT05642780
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
PHASE2Active, not recruiting
240 participants
Started: Jan 17, 2023 · Completed: Dec 31, 2027
1 condition6 sponsors48 locations
NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
PHASE1/PHASE2Active, not recruiting
1,410 participants
Started: Feb 28, 2020 · Completed: Jul 16, 2026
10 conditions1 sponsor109 locations